APA (7th ed.) Citation

Compter, I., Oldoni, E., Houben, R., Van der Weijst, L., De Ruiter, M., Goris, A., . . . De Ruysscher, D. (2020). PO-1676: Blood biomarkers for cognitive damage after PCI; an exploratory analysis of the HA-PCI phase 3 trial. Radiotherapy & Oncology, 152, S921. https://doi.org/10.1016/S0167-8140(21)01694-7

Chicago Style (17th ed.) Citation

Compter, I., et al. "PO-1676: Blood Biomarkers for Cognitive Damage After PCI; an Exploratory Analysis of the HA-PCI Phase 3 Trial." Radiotherapy & Oncology 152 (2020): S921. https://doi.org/10.1016/S0167-8140(21)01694-7.

MLA (9th ed.) Citation

Compter, I., et al. "PO-1676: Blood Biomarkers for Cognitive Damage After PCI; an Exploratory Analysis of the HA-PCI Phase 3 Trial." Radiotherapy & Oncology, vol. 152, 2020, p. S921, https://doi.org/10.1016/S0167-8140(21)01694-7.